Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
23.04
+0.85 (3.82%)
Nov 21, 2024, 12:00 PM EST - Market open
Rapport Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 843 | - | - |
| Enterprise Value | 493 | - | - |
| Debt / Equity Ratio | 0.01 | 0.05 | 0.53 |
| Quick Ratio | 45.17 | 16.75 | 18.74 |
| Current Ratio | 45.91 | 17.14 | 18.80 |
| Return on Equity (ROE) | - | -43.36% | - |
| Return on Assets (ROA) | - | -24.18% | - |
| Return on Capital (ROIC) | - | -25.52% | - |
| Buyback Yield / Dilution | -1491.15% | -93.74% | - |
| Total Shareholder Return | -1491.15% | -93.74% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.